08 January 2024
|
3
min read

In this Financial Times article by Hannah Kuchler, Genomics plc is featured following its successful £35 million funding round. The piece highlights how the Oxford University spinout is using polygenic risk scores to predict disease and support a shift toward more proactive, personalised healthcare.
This article was originally published in The Financial Times.